Health Care & Life Sciences » Biotechnology | Advanced Proteome Therapeutics Corp.

Advanced Proteome Therapeutics Corp. | Income Statement

Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
80.60
25.00
20.20
15.80
11.00
7.40
Gross Income
80.60
25.00
20.20
15.80
11.00
7.40
SG&A Expense
1,011.90
1,077.50
1,562.30
1,107.10
1,414.90
1,481.90
EBIT
1,092.50
1,102.50
1,582.60
1,122.90
1,425.90
1,489.30
Unusual Expense
111.60
333.20
195.30
13.60
307.50
445.30
Non Operating Income/Expense
8.20
27.40
52.00
6.20
24.70
4.50
Interest Expense
42.50
7.60
8.40
9.40
50.60
89
Pretax Income
1,254.30
1,470.00
1,343.00
1,152.10
1,193.70
1,137.40
Consolidated Net Income
1,254.30
1,470.00
1,343.00
1,152.10
1,193.70
1,137.40
Net Income
1,028.30
1,233.90
1,056.50
893.60
955.40
948.70
Net Income After Extraordinaries
1,028.30
1,233.90
1,056.50
893.60
955.40
948.70
Net Income Available to Common
1,028.30
1,233.90
1,056.50
893.60
955.40
948.70
EPS (Basic)
0.01
0.01
0.01
0.01
0.01
0.06
Basic Shares Outstanding
85,426.00
99,583.60
109,566.80
114,033.50
123,971.40
14,993.30
EPS (Diluted)
0.01
0.01
0.01
0.01
0.01
0.06
Diluted Shares Outstanding
85,426.00
99,583.60
109,566.80
114,033.50
123,971.40
14,993.30
EBITDA
1,062.20
1,077.50
1,562.40
1,107.10
1,414.90
1,481.90
Non-Operating Interest Income
0.50
0.70
0.70
0.00
0.00
-
Minority Interest Expense
225.90
236.10
286.50
258.50
238.30
188.70

About Advanced Proteome Therapeutics

View Profile
Address
BioSquare
Boston Massachusetts 02118
United States
Employees -
Website http://www.advancedproteome.com
Updated 07/08/2019
Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development of anti-cancer therapeutics. It also commercializes technology platform that is intended for the chemical modification of protein therapeutics. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.